Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Aviv Regev will become head of research and early development at Roche’s Genentech unit on Aug. 1. She will replace Michael Varney, an organic chemist who is retiring after 15 years with Genentech. Regev, a computational biologist, has posts at the Massachusetts Institute of Technology, the Broad Institute of MIT and Harvard, and the Howard Hughes Medical Institute.
This article has been sent to the following recipient: